RPL21P24

Across TCGA pan-cancer cohorts, RPL21P24 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL21P24 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPL21P24 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL21P24 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

BLCA, BRCA, and THYM are the cancer types where RPL21P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.536	0.732	.008	48	view →
BRCA	OS	Tertile	II,III,IV	0.789	0.919	.001	39	view →
THYM	OS	Tertile	All	0.489	0.912	<.001	36	view →
PAAD	OS	Tertile	All	0.159	0.596	<.001	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	27	view →
LGG	DFS	Tertile	All	0.136	0.435	<.001	21	view →
SKCM	OS	Tertile	III,IV	0.396	0.715	.006	15	view →
KIRC	DFS	Quartile	All	0.752	0.542	.012	12	view →
ESCA	DFS	Tertile	II,III,IV	0.341	0.815	.034	9	view →
LIHC	OS	Tertile	All	0.201	0.577	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPL21P24–BLCA (OS)

Open the BLCA breakdown →